Molecular Neurobiology

Special Issues

Following special issues within this section are currently open for submissions:

• Pathophysiology and Pharmacology in Psychiatry (Deadline: 20 April 2026)
• The Blood–Brain Barrier and Neuroprotection (Deadline: 20 April 2026)
• Physiological Functions and Pathological Effects of Microglia (Deadline: 20 April 2026)
• The Role of the Endocannabinoid System in Reward- and Addiction-Related Neuroplasticity (Deadline: 20 April 2026)
• Amyotrophic Lateral Sclerosis Behind Motor Neurons (Deadline: 20 April 2026)
• Advancement of Understanding Alzheimer’s Disease Susceptibility and Novel Drug Targets (Deadline: 20 April 2026)
• Molecular Signatures in Autism Spectrum Disorders (Deadline: 20 April 2026)
• Pathogenic Proteins in Neurodegenerative Diseases: From Pathogenesis to Therapeutic Innovations (Deadline: 20 April 2026)
• Unveiling Molecular Mysteries of Brain Barriers (Deadline: 20 April 2026)
• Multiple Sclerosis: From Molecular Mechanisms to Pathophysiology (Deadline: 20 April 2026)
• Molecular, Cellular and Systems Research on Neuroanatomy, Brain Function and Its Impact on Human Behavior (Deadline: 20 April 2026)
• Neurotoxicity: Cellular Death Mechanisms in the Pathogenesis of Neurodegenerative Diseases (Deadline: 20 April 2026)
• Mechanosensitive Ion Channels in the Nervous System (Deadline: 20 April 2026)
• Neurogenesis and Neurodegeneration: Insights into Regeneration and the Impact of Neurotrophins (Deadline: 20 April 2026)
• Molecular Mechanism and Pharmacological Target of Neuroprotection (Deadline: 20 April 2026)
• Advances in Epigenetics of Mental Disorders (Deadline: 20 April 2026)
• Natural Products for Neuroprotection and Neurodegeneration (Deadline: 20 April 2026)
• Molecular Insights in Neurodegeneration (Deadline: 20 April 2026)
• Advanced Molecular Diagnostic Approaches for Neurodevelopmental Disorders: Applications and Future Perspectives (Deadline: 20 April 2026)
• Alzheimer’s Disease: Molecular Mechanisms and Novel Therapies (Deadline: 20 April 2026)
• New Insights and Discoveries in the Pathogenesis, Diagnosis and Therapy of Neuromuscular Diseases (Deadline: 20 April 2026)
• Molecular Advances in Neuroimaging (Deadline: 20 April 2026)
• Translational Neuroscience of Emotion, Cognition, and Behavior: From Mechanisms to Mental Health (Deadline: 20 April 2026)
• Dysfunctional Neural Circuits and Impairments in Brain Function, 2nd Edition (Deadline: 30 April 2026)
• Molecular Insights and Therapeutic Innovations in Neuromuscular Diseases (Deadline: 30 April 2026)
• The Role of Dopamine Neurotransmission in Schizophrenia (Deadline: 30 April 2026)
• Molecular Mechanisms of Maternal Effects on Infant Neurodevelopment (Deadline: 30 April 2026)
• Molecular Biomarkers in Mood Disorders (Deadline: 30 April 2026)
• Advances in Neurorepair and Regeneration (Deadline: 30 April 2026)
• Research on New Targets and New Drugs for Dementia (Deadline: 30 April 2026)
• From Molecular Insights to Novel Therapies: Neurological Diseases (Deadline: 20 May 2026)
• The Function of Glial Cells in the Nervous System: 2nd Edition (Deadline: 20 May 2026)
• Glial Cells in Neurodegenerative Disorders (Deadline: 20 May 2026)
• Challenges of Acute Ischemic Stroke (Deadline: 20 May 2026)
• Amyotrophic Lateral Sclerosis (ALS): Pathogenesis and Treatments (Deadline: 20 May 2026)
• Molecular Diagnostics in Neurological Diseases (Deadline: 20 May 2026)
• Molecular Research in Epilepsy and Epileptogenesis—2nd Edition (Deadline: 20 May 2026)
• Gut–Brain Axis: Pathophysiological Mechanisms in Neurological Disorders and Metabolic Diseases (Deadline: 20 May 2026)
• Emerging Biological and Molecular Targets in Schizophrenia (Deadline: 20 May 2026)
• Neurological Diseases: From Physiology to Therapy (Deadline: 20 May 2026)
• Perineuronal Nets and Fear Memories Erasure: State of the Art and Future Directions (Deadline: 20 May 2026)
• Blood–Brain Barrier Dysfunction in Neurodegenerative Disorders (Deadline: 20 May 2026)
• Recent Advances in Neurofibromatosis Type 1: From Molecular Insights to Novel Therapies (Deadline: 20 May 2026)
• Unraveling the Molecular Landscape of Primary Brain Tumors (Deadline: 20 May 2026)
• Neuropeptides in Brain Health and Disease: From Molecular Mechanisms to Therapeutic Potential (Deadline: 20 May 2026)
• AI and Machine Learning in Molecular Biomarker Discovery and Mechanisms of Neurodegenerative Disorders (Deadline: 20 May 2026)
• Latest Research in Neuroinflammation (Deadline: 20 May 2026)
• Latest Research in Alzheimer’s Disease (Deadline: 20 May 2026)
• Cutting-Edge Research and Advancements in Neurodegenerative Diseases (Deadline: 25 May 2026)
• Decoding Parkinson’s: Molecular Symphonies and Dysregulated Pathways (Deadline: 30 May 2026)
• New Therapeutic Targets for Neuroinflammation and Neurodegeneration (Deadline: 31 May 2026)
• Cellular and Molecular Mechanisms of Neuroinflammation (Deadline: 31 May 2026)
• Molecular and Systems Mechanisms of Neural Circuit Function and Plasticity (Deadline: 31 May 2026)
• Neurological Mechanisms of Action of Natural Products (Deadline: 31 May 2026)
• Metabolic Dysfunction in Brain Disorders: Molecular Pathways and Therapeutic Approach (Deadline: 31 May 2026)
• Advances in Pathogenesis, Biomarkers, and Therapeutic Development in Huntington’s Disease (Deadline: 31 May 2026)
• Integrative Mechanisms and Translational Outcomes of Excitatory–Inhibitory Neurotransmission Switching in Neuropathic Pain (Deadline: 31 May 2026)
• Epilepsy: Molecular Neuropharmacology, Calcium Signalling, Neuroinflammation, and Drug Discovery (Deadline: 31 May 2026)
• Multi-Omics Approaches to Disentangle Pathomechanisms in Neurological Disease (Deadline: 20 June 2026)
• Molecular Basis of Neuropsychiatric Disorders: Recent and Future Developments (Deadline: 20 June 2026)
• The Current Landscape of Microglia-Glioma Research: From Basic Science to Therapeutic Potential (Deadline: 20 June 2026)
• Molecular Research in Epilepsy (Deadline: 20 June 2026)
• Molecular Research on Stroke (Deadline: 20 June 2026)
• Effects of Chemicals on Brain Health and Development (Deadline: 20 June 2026)
• Molecular Advances in Biomarkers of Central Nervous System Diseases and Disorders (Deadline: 20 June 2026)
• Neuroinflammation: Emerging Insights and Advances in Drug Development (Deadline: 20 June 2026)
• Wired for Change: Neurotransmitter Plasticity and Circuit Dynamics in Health and Disease (Deadline: 20 June 2026)
• Microglia in Neurological Disorders: Potential Therapeutic Targets and Underlying Mechanisms (Deadline: 20 June 2026)
• Neurobiology and Psychopharmacology of Mood Disorders (Deadline: 20 June 2026)
• Brain Stroke Across the Lifespan: Mechanisms, Models, Translational Advances and Impacts Beyond the Brain (Deadline: 20 June 2026)
• Molecular Crosstalk in Stress-Induced Psychopathology (Deadline: 20 June 2026)
• Detrimental and Beneficial Roles of Glial Cells After Neural Disorders (Deadline: 20 June 2026)
• Molecular and Cellular Mechanism in Neuroinflammation Research (Deadline: 20 June 2026)
• Recent Advances in Metabolism of Alzheimer’s Disease (Deadline: 20 June 2026)
• Molecular and Genetic Insights into Neuropsychiatric Disorders: From Mechanisms to Management (Deadline: 20 June 2026)
• Current Developments in Glioblastoma Research and Therapy: 2nd Edition (Deadline: 30 June 2026)
• Molecular Mechanisms and Pathophysiology of Peripheral Neuropathies and Neuromuscular Disorders (Deadline: 30 June 2026)
• Unraveling Affective Disorders: From Pathogenesis to Drug Therapy (Deadline: 30 June 2026)
• Anesthetics and Neurovascular Health: Molecular Pathways (Deadline: 30 June 2026)
• Advances in Alzheimer’s Disease (Deadline: 30 June 2026)
• Advancing Molecular Psychiatry: Biomarkers, Mechanisms, and Precision Therapeutics (Deadline: 30 June 2026)
• Advances in Molecular Pathobiology, Diagnosis, and Treatment of Neurodegenerative Diseases (Deadline: 30 June 2026)
• Psychedelics and Mental Disorders: From Molecular Mechanisms to Therapies Potential (Deadline: 30 June 2026)
• Molecular Advances in Quantum Neuroactivity (Deadline: 30 June 2026)
• Molecular Mechanisms and Signaling Pathways in Alzheimer’s Disease (Deadline: 20 July 2026)
• Neuronal Differentiation: From Pathology to Therapeutic Strategies (Deadline: 20 July 2026)
• Molecular Insights into Addiction (Deadline: 20 July 2026)
• Development of Dopaminergic Neurons, 4th Edition (Deadline: 20 July 2026)
• Role of Mitochondria in Neurodegenerative Diseases (Deadline: 20 July 2026)
• Neurodegenerative Disorders: Advances in Mechanisms, Models, and Therapeutics (Deadline: 20 July 2026)
• Advancing Mental Disorder Therapies: Drug Repositioning and Translational Insights from Animal Models (Deadline: 20 July 2026)
• Neurodegenerative Diseases: Molecular Mechanisms and Therapies, 4th Edition (Deadline: 25 July 2026)
• Emerging Roles of Extracellular Vesicles in Neurological Diseases (Deadline: 25 July 2026)
• Neurobiology Linking Alcohol Addiction to Psychiatry Symptoms (Deadline: 30 July 2026)
• Molecular Determinants of Neuromotor Control, Tremor, and Fatigue (Deadline: 30 July 2026)
• Molecular and Cellular Mechanisms Underlying Chronic Pain (Deadline: 30 July 2026)
• Physiology and Pathophysiology of Neurodegeneration: New Insights and Advances from Molecular to Cellular Level (Deadline: 31 July 2026)
• New Insights into Chronic Inflammatory Demyelinating Polyneuropathy and Neuroimmunological Diseases (Deadline: 31 July 2026)
• The Brain’s Regeneration Potential: The Role of Neural Progenitor Cells in Neuropsychiatric Therapy (Deadline: 31 July 2026)
• Drug Development and Discovery for Alzheimer's Disease (Deadline: 31 July 2026)
• Molecular Signatures in Overt Neurodegenerative Disease: Toward Precision Diagnosis and Classification (Deadline: 31 July 2026)
• Circulating Biomarkers for the Diagnosis of Neurobiological Diseases—3rd Edition (Deadline: 31 July 2026)
• Neurofibromatosis Type 1 and NF2-Related Schwannomatosis: Advances from Basic Research to Current Therapies (Deadline: 31 July 2026)
• Molecular Insights in Neuro-Ophthalmology (Deadline: 31 July 2026)
• Recent Advances in Neuroprotective Drug Development and Therapeutic Applications (Deadline: 31 July 2026)
• Latest Advances in Gut–Brain Axis Research (Deadline: 31 July 2026)
• Molecular Mechanisms of Early-Life Environmental Effects on Brain Development (Deadline: 31 July 2026)
• Molecular Investigations in Neurodevelopmental Disorders: 2nd Edition (Deadline: 31 July 2026)
• Mechanisms and Therapeutic Strategies for Cognitive Dysfunction (Deadline: 31 July 2026)
• Genetic and Molecular Mechanisms in Neurological Diseases (Deadline: 31 July 2026)
• Advances in Neurodegenerative Diseases: Research, Challenges, and Perspectives (Deadline: 31 July 2026)
• Molecular Insights into Gangliosides (Deadline: 31 July 2026)
• Advances in Neurodegenerative Diseases Research and Therapy, Fourth Edition (Deadline: 31 July 2026)
• New Mechanisms and Therapeutics in Neurological Diseases—5th Edition (Deadline: 31 July 2026)
• Molecular Pathological and Genetic Studies of Alzheimer's Disease and Parkinson's Disease (Deadline: 10 August 2026)
• Molecular Mechanisms Underlying Vulnerability to Stress-Related Disorders (Deadline: 20 August 2026)
• New Advances in the Treatment and Diagnosis of Neuromuscular Diseases (Deadline: 20 August 2026)
• Multiple Sclerosis: From Molecular Pathology to Novel Therapeutic Approaches (Deadline: 20 August 2026)
• Molecular Research on Depression—2nd Edition (Deadline: 20 August 2026)
• Natural Compounds in Neurological Diseases (Deadline: 20 August 2026)
• Advances in Amyloid Aggregation and Its Inhibition: Implementing Insights from Physiological Conditions (Deadline: 20 August 2026)
• Neurodegenerative Diseases: Genetic Bases and Pathogenetic Mechanisms (Deadline: 20 August 2026)
• 25th Anniversary of IJMS: Updates and Advances in Molecular Neurobiology (Deadline: 20 August 2026)
• Molecular Perspective of Alzheimer’s Disease (Deadline: 20 August 2026)
• Gene Regulation and Neurotoxicity in Alcohol Related Pathologies (Deadline: 20 August 2026)
• Molecular Insights into Microglia in Neurological Diseases (Deadline: 20 August 2026)
• New Insights into the Mechanisms of Neurodegeneration and Regeneration: From Bench to Bedside (Deadline: 20 August 2026)
• Neuropharmacological Innovations in Treating Neurodegenerative Diseases (Deadline: 20 August 2026)
• The Cellular and Molecular Mechanisms of Central Nervous System Injury (Deadline: 20 August 2026)
• Mechanisms of Action of Environmental Neurotoxicants During Critical Periods of Brain Development (Deadline: 20 August 2026)
• From Synapse to Substance Use: Endocannabinoids and Cannabinoid Receptors in Brain Plasticity and Addiction Circuits (Deadline: 20 August 2026)
• New Advances in Amyotrophic Lateral Sclerosis (Deadline: 20 August 2026)
• New Therapies for CNS Diseases Targeting Biogenic Amines and Their Receptors (Deadline: 20 August 2026)
• The Cellular and Molecular Mechanisms of Sensory Map Development (Deadline: 25 August 2026)
• Neurotransmitter Dysregulation in Brain Disease: Focus on Epilepsy and Its Comorbidities (Deadline: 30 August 2026)
• Molecular Mechanisms Fueling Glioblastoma Progression and Resistance: Emerging Therapeutic Opportunities (Deadline: 30 August 2026)
• Protein Regulation and Targeted Therapeutics in Neurodegenerative Disorders (Deadline: 30 August 2026)
• Advances in Neurodevelopmental Toxicity (Deadline: 30 August 2026)
• Dopamine, Histamine, Serotonin—Receptors, Ligands and Their Biological Role in Central Nervous System Diseases, 2nd Edition (Deadline: 31 August 2026)
• Anti-Inflammatory Strategies and Cell Models for Alzheimer’s Disease (Deadline: 31 August 2026)
• Neuroinflammation and Cellular Senescence in Brain Aging and Neurodegeneration: From Molecular Mechanisms to Therapeutic Applications (Deadline: 31 August 2026)
• Advances in the Molecular Diagnosis and Treatment of Neurodegenerative Diseases (Deadline: 31 August 2026)
• Microbiota and Gut–Brain–Eye Neuromodulators in Neurodegenerative Disorders: Biomolecular Targets and Therapeutic Challenges (Deadline: 31 August 2026)
• Mechanisms and Pathways of Actions for Nutritional Effects on Brain Health (Deadline: 31 August 2026)
• The Role of Neuropeptides and Their GPCRs in the Neuroendocrine System (Deadline: 31 August 2026)
• Molecular and Translational Research on Late-Life Cognitive and Neuropsychiatric Disorders (Deadline: 31 August 2026)
• Animal Models for Neurobiological Diseases (Deadline: 31 August 2026)
• Advances in Alzheimer's Disease and Related Dementias: From Pathogenesis to Therapeutics (Deadline: 31 August 2026)
• Molecular Neuropathology of Alzheimer’s Disease: Tau, Amyloid-β, and Novel Protein Associations (Deadline: 31 August 2026)
• Advances in Neuropharmacology: From Molecular Design to Preclinical Models (Deadline: 31 August 2026)
• Traumatic Brain Injury and Alzheimer's Disease: From Pathogenesis to Therapy (Deadline: 31 August 2026)
• Bringing New Molecular Insights into Neurodegenerative Diseases (Deadline: 31 August 2026)
• Multi-Omics Perspectives on Psychiatric Disorders: From Molecular Mechanisms to Clinical Translation (Deadline: 31 August 2026)
• Brain–Organ Axis and Related Neurodegeneration (Deadline: 31 August 2026)
• Research in Cannabinoid Therapeutics: Novel Insights and Products (Deadline: 31 August 2026)
• Recent Research in Cerebellar Development and Disease (Deadline: 31 August 2026)
• Recent Molecular Insights into Alzheimer's Disease (Deadline: 31 August 2026)
• Role of Glia in Human Health and Disease—2nd Edition (Deadline: 31 August 2026)
• Photoreceptors and the Optic Nerve (Deadline: 31 August 2026)
• Depression: From Molecular Basis to Therapy—3rd Edition (Deadline: 31 August 2026)
• Molecular Targets and Toxic Interactomes of Pathogenic Proteins in Neurodegeneration (Deadline: 31 August 2026)
• Drug Delivery to the Central Nervous System: From Design, Synthesis, and Evaluation (Deadline: 20 September 2026)
• Neuroimaging Studies in Exploring the Molecular Mechanisms of Neurological Diseases (Deadline: 20 September 2026)
• Progression of Multiple Sclerosis: Environmental Factors, Genetics, Therapeutics and Immunopathogenesis (Deadline: 20 September 2026)
• Contribution of Astrocytes and Microglia for the Development of Neurological Disorders (Deadline: 20 September 2026)
• Parkinson’s Disease and Related Diseases: Mechanisms, Genetic Factors and Treatments (Deadline: 20 September 2026)
• Neuromodulatory Effects of Serotonin, 2nd Edition (Deadline: 20 September 2026)
• Molecular Mechanisms and Neural Circuits in Behavioral Neuroscience (Deadline: 20 September 2026)
• New Challenges of Parkinson’s Disease, 2nd Edition (Deadline: 20 September 2026)
• Molecular Aspects of Retinal Neurodegeneration and Neuroprotection (Deadline: 20 September 2026)
• New Trends in Alzheimer’s Disease Research: From Molecular Mechanisms to Therapeutics: 3rd Edition (Deadline: 20 September 2026)
• Effects of Natural Products on Neurological Diseases (Deadline: 20 September 2026)
• Drug Discovery and Preclinical Pharmacology for Cognitive and Neuropsychiatric Disorders in Aging (Deadline: 20 September 2026)
• Neurodegenerative Diseases: Molecular Mechanisms, Drug Targets and Therapeutic Strategies (Deadline: 20 September 2026)
• Recent Prospects in Neurons (Deadline: 20 September 2026)
• Molecular Mechanism and Pathogenesis of Neuroinflammation in Neurological Disorders (Deadline: 20 September 2026)
• Genetic Advances in Neurobiology of Health and Disease (Deadline: 20 September 2026)
• Molecular Basis of Proteinopathies in Neurodegenerative Diseases (Deadline: 20 September 2026)
• Current Research on Neuroprotective Phytochemicals and Their Multi-Target Mechanisms (Deadline: 20 September 2026)
• Neurological Diseases: From Pathogenesis to Molecular Diagnosis and Treatment (Deadline: 20 September 2026)
• Advances in Diagnostics and Therapeutics of Neurodegenerative Disease (Deadline: 20 September 2026)
• Molecular Synapse: Diversity, Function and Signaling (Deadline: 20 September 2026)
• Exploring Glia: New Insights into Neurobiology and Therapeutic Potential (Deadline: 20 September 2026)
• Advances in Alzheimer’s Disease: From Metabolic Dysregulation to Molecular Pathophysiology and Therapeutics (Deadline: 20 September 2026)
• Research on Stem Cells in Neurological Disorders: Disease Modeling and Therapy (Deadline: 20 September 2026)
• Research Advances in Circuit Mechanisms of Neurodegenerative Diseases (Deadline: 20 September 2026)
• Genetic Diversity, Founder Effects, and Migration in Neurodegeneration: Molecular and Population Perspectives (Deadline: 30 September 2026)
• Stress-Related Disorders and Depression: From Molecular Basis to Therapy (3rd Edition) (Deadline: 30 September 2026)
• Molecular Insights into Genetic and Epigenetic Alterations in Age-Related Diseases (Deadline: 30 September 2026)
• A Window to the Brain: From Retinal Cellular and Soluble Biomarkers Towards Neurodegeneration (Deadline: 30 September 2026)
• Molecular Targeting in Neuroinflammation: Uncovering Mechanisms, Pharmacological Targets and Neuropharmaceutical Developments (Deadline: 30 September 2026)
• Neurochemical and Biochemical Mechanisms of Depressive Disorders (Deadline: 30 September 2026)
• Challenges and Innovation in Neurodegenerative Diseases, 3rd Edition (Deadline: 30 September 2026)
• State-of-the-Art Molecular Neurobiology in Malaysia (Deadline: 30 September 2026)
• Modeling Neurogenesis, Regeneration and Disease from Animal Models (Deadline: 30 September 2026)
• Molecular and Histological Advance in Neural Regeneration (Deadline: 30 September 2026)
• Neuroimmune Interactions: From Physiology to Pathology (Deadline: 30 September 2026)
• Molecular Mechanisms Underlying Genetic Variants of Parkinson’s Disease (Deadline: 30 September 2026)
• Epigenetic Studies of Mental Illness (Deadline: 30 September 2026)
• Advances in Neuroscience of Mental Disorders: Neuropsychological, Neurobiological and Neuromolecular Perspectives (Deadline: 30 September 2026)
• New Advances in Infectious and Immunoinflammatory Mechanisms of Alzheimer's Disease (Deadline: 30 September 2026)
• Activation of the Blood–Brain Barrier and Neurological Dysfunction: 2nd Edition (Deadline: 20 October 2026)
• Zebrafish Model for Neurological Research (Deadline: 20 October 2026)
• Immunity in Neurodegenerative Diseases: Systemic Immune Imbalance, Neuroinflammation, and Beyond—2nd Edition (Deadline: 20 October 2026)
• Molecular Insights into Cerebrovascular Diseases (Deadline: 20 October 2026)
• Molecular Mechanisms and Pathophysiology of Nerve Regeneration (Deadline: 20 October 2026)
• Neurodegenerative Disease: From Molecular Basis to Therapy, 5th Edition (Deadline: 20 October 2026)
• Neural Damage and Fibrosis: From Mechanisms to Therapy (Deadline: 20 October 2026)
• Statin Induced Neurotoxicity (Deadline: 23 October 2026)
• Advances in Aging and Alzheimer’s Disease Research: From Molecular Mechanisms to Therapeutics—2nd Edition (Deadline: 23 October 2026)
• Latest Advances in Oxidative Stress and Brain Injury (Deadline: 23 October 2026)
• Metabolic–Epigenetic Interplay in Health and Diseases (Deadline: 23 October 2026)
• Research Progress on Neuroinflammation (Deadline: 25 October 2026)
• Molecular Insights into Role of Anthranilic Acid in Neuropsychiatric Diseases (Deadline: 30 October 2026)
• Precision Targets for Brain Health: The Molecular Era of Neuropharmacology (Deadline: 30 October 2026)
• The Latest Molecular and Psycho-Physiological Insights on “Brain Fatigue” (Deadline: 31 October 2026)
• Molecular Insights into Anxiety and Depression: Pathomechanisms and Therapeutic Strategies (Deadline: 31 October 2026)
• The Expanding Genetic Landscape of Parkinson's Disease (Deadline: 31 October 2026)
• Functional and Hybrid Imaging in Molecular Neuroscience (Deadline: 31 October 2026)
• Recent Advances in Dementia with Lewy Bodies (DLB) and Alzheimer’s Disease (AD) (Deadline: 31 October 2026)
• Unraveling Neurodevelopmental Disorders: A Molecular Perspective (Deadline: 31 October 2026)
• Molecular Mechanisms of Dysfunctional Neural Circuits in Brain Disorders (Deadline: 31 October 2026)
• Mechanistic Studies of Neuroplasticity (Deadline: 31 October 2026)
• Unraveling the Molecular Mechanisms of Neurodegeneration (Deadline: 20 November 2026)
• Molecular Mechanisms and Emerging Therapies in Neurovascular Disease (Deadline: 20 November 2026)
• Peripheral Neuropathies: Molecular Research and Novel Therapy—2nd Edition (Deadline: 20 November 2026)
• Molecular Targeting and Pharmacology of Neuroinflammation (Deadline: 27 November 2026)
• Molecular Research on Central Nervous System Inflammatory Demyelinating Diseases (Deadline: 30 November 2026)
• Molecular Mechanisms of Nerve Injury and Regeneration (Deadline: 30 November 2026)
• Molecular Research on Inflammation in Neurodegenerative Diseases (Deadline: 1 December 2026)
• From Molecules to Cognition: Biomarkers and Neuropsychological Tools in Neurological Disorders (Deadline: 20 December 2026)
• Neurological and Neurodevelopmental Disorders: Models, Drugs and Technologies (Deadline: 20 December 2026)
• Molecular Mechanism of Sympathetic Nerves in Cardiovascular Diseases and Cancer (Deadline: 25 December 2026)
• Molecular Mechanisms and Translational Insights in Neurological Disorders (Deadline: 31 December 2026)
• Advanced Biomaterials for Neural Regeneration and Axogenesis: From Cellular Support to Functional Recovery (Deadline: 31 December 2026)
• Molecular Mechanisms of Neurodevelopment, Neuroprotection, and Brain Health (Deadline: 31 December 2026)

Topical Collections

Following topical collections within this section are currently open for submissions:

• Feature Papers in Molecular Neurobiology
• Latest Review Papers in Molecular Neurobiology
• Novel Insights into the Sleeping, Waking, and Dreaming Brain